Position in BLLN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$7,511,929
+$1,668,557 QoQ
Shares Held
95,160
+33.3% QoQ
Ownership
0.207%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026BlackRock, Inc. holds $54,004,955,805 across 42 Diagnostics & Research names. BLLN ranks #32 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
30,427,192 | $14,955,877,673 | |
| 2 | DHR |
Danaher Corp /De/
|
51,640,619 | $9,791,061,354 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
8,365,553 | $4,700,520,563 | |
| 4 | A |
Agilent Technologies, Inc.
|
25,902,662 | $2,952,385,405 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
15,027,444 | $2,562,780,290 | |
| 6 | WAT |
Waters Corp /De/
|
8,543,014 | $2,544,109,560 | |
| 7 | ILMN |
Illumina, Inc.
|
19,023,590 | $2,344,847,691 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
1,771,002 | $2,233,587,712 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,511,929 | 95,160 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $5,843,372 | 71,400 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||